Promising Compounds From Murraya exotica for Cancer Metastasis Chemoprevention

Area of Science:

• Phytochemistry
• Cancer Biology
• Pharmacology

Background:

• Current anticancer drugs primarily target tumor cell death, neglecting metastasis.
• Inflammation and tumor invasion share common mechanisms, suggesting anti-inflammatory agents may inhibit metastasis.
• Murraya exotica possesses known anti-inflammatory properties, making it a candidate for metastasis chemoprevention.

Purpose of the Study:

• To evaluate the chemopreventive potential of Murraya exotica extracts and a novel coumarin against cancer metastasis.
• To compare the efficacy of leaf and root extracts of Murraya exotica in inhibiting cancer cell migration and adhesion.
• To assess the cytotoxicity of the evaluated compounds.

Main Methods:

• In vitro experiments using MDA-MB-231 breast cancer cells.
• Assessment of cell migration and cell adhesion inhibition by leaf and root extracts.
• Evaluation of a novel coumarin isolated from root extracts.
• Cytotoxicity assays to determine safety profiles.

Main Results:

• Murraya exotica root extracts demonstrated superior inhibition of cancer cell migration compared to leaf extracts.
• Leaf extracts showed slightly stronger inhibition of tumor cell adhesion at lower concentrations.
• A novel coumarin from root extracts exhibited comparable cell adhesion inhibition but less migration inhibition than root extracts.
• All tested extracts displayed low in vitro cytotoxicity.

Conclusions:

• Murraya exotica extracts contain compounds with promising anti-metastatic properties.
• Further research into M. exotica for cancer metastasis chemoprevention is warranted.
• Specific compounds from M. exotica may offer a novel therapeutic strategy against cancer spread.